Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.482NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.482NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.482NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.3.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.3.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GY.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GY.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.3.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.3.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JC.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JC.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.564NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.564NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.564NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.461NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.461NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.461NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-20964.7China
B.1.1.486NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.486NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.486NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.603NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.603NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.603NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.70NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.70NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
B.1.1.70NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.606NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.606NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.606NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.601NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.601NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.601NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.186NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.186NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.186NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.324NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.324NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.324NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.2.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.2.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JC.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used